Beer Marc D - Insider Stock Trading - OpenInsider

CIK: 1314575 - Address: C/O Biote Corp., 1875 W. Walnut Hill Ln #100, Irving, TX 75038

17 results

TC	Stat	Stk	Ins	Fil	+d	+w	+m	+q	+h	+y	avg
P	%ret	2	1	16	0	2	0	3	0	13	3
P	%wins				63	56	44	53	53	33	50

Filing Date	T Date	Ticker	Issuer	Inc	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	L	Qty	oc	Own	H	r2y	r1y	r6m	r3m	r6w	r3w	r7d	r3d	f1d	f1w	f1m	f3m	f6m	f1y
3/18/25 19:43	3/17/25	BTMD	Biote Corp.		Health	MdCm	Medicinal Chemicals & Botanic	Beer Marc D	TX	D		P	417	3.87	0	108	New	108	D
3/21/17 08:34	3/17/17	NERV	Minerva Neurosciences, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Beer Marc D	MA	D		P.m	406	8.12	2	50	New	50	D	28	34	-46	-42	-29	-11	-8	-9	-1	9	-7
7/31/14 12:30	7/31/14	AEGR	Aegerion Pharmaceuticals, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Beer Marc D	MA	DO	CEO	P	337	33.65	33	10	3	326	D	139	-57	-38	-19	2	24	30	19	-6	-8	-14	-5	-35	-47
6/4/14 09:30	6/3/14	AEGR	Aegerion Pharmaceuticals, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Beer Marc D	MA	DO	CEO	P	301	30.12	33	10	3	316	D	110	-58	-57	-46	-32	-8	-3	-3	8	12	6	0	-32	-38
5/27/14 12:57	5/27/14	AEGR	Aegerion Pharmaceuticals, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Beer Marc D	MA	DO	CEO	P	316	31.59	33	10	3	306	D	119	-48	-51	-54	-23	-28	-4	4	2	-4	6	-5	-34	-36
5/21/14 09:40	5/20/14	AEGR	Aegerion Pharmaceuticals, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Beer Marc D	MA	DO	CEO	P	305	30.53	33	10	4	289	D	108	-50	-59	-51	-27	-31	-7	-8	4	7	14	1	-34	-34
5/8/14 10:20	5/8/14	AEGR	Aegerion Pharmaceuticals, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Beer Marc D	MA	DO	CEO	P	1,059	35.31	33	30	12	279	D	153	-19	-58	-41	-23	-20	-21	-20	-5	-5	-2	-6	-39	-40
3/30/12 09:19	3/29/12	AEGR	Aegerion Pharmaceuticals, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Beer Marc D	MA	DO	CEO	P	14	13.74	1	1	0	404	D		-20	-4	-14	-22	-14	-7	-2	1	2	-9	4	8	179
3/23/12 10:02	3/22/12	AEGR	Aegerion Pharmaceuticals, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Beer Marc D	MA	DO	CEO	P	14	13.96	1	1	0	402	D		-17	-5	-15	-17	-18	-12	-7	0	-2	-13	3	6	175
9/6/11 13:59	9/1/11	AEGR	Aegerion Pharmaceuticals, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Beer Marc D	MA	DO	CEO	P	100	14.75	1	7	2	402	M			-5	-19	-10	-1	2	0	4	6	-4	18	1	3
8/10/11 09:42	8/9/11	AEGR	Aegerion Pharmaceuticals, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Beer Marc D	MA	DO	CEO	P	120	11.95	1	10	3	388	M			2	-29	-8	-6	-10	-2	-7	0	6	6	20	-4
8/3/11 14:30	8/1/11	AEGR	Aegerion Pharmaceuticals, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Beer Marc D	MA	DO	CEO	P	100	15.74	1	6	2	362	M			14	-19	-15	-3	-3	-3	-2	-6	-4	-13	15	-1
6/29/11 14:54	6/29/11	AEGR	Aegerion Pharmaceuticals, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Beer Marc D	MA	DO	CEO	P	1,000	15.50	3	65	55	181	D			4	-13	-9	-11	-13	-1	3	4	2	-2	8	-4
6/3/11 09:00	6/1/11	AEGR	Aegerion Pharmaceuticals, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Beer Marc D	MA	DO	CEO	P.d	100	18.70	1	5	2	344	M			60	15	4	-12	1	-6	2	-3	-10	-16	-7	-17
4/5/11 17:00	4/4/11	AEGR	Aegerion Pharmaceuticals, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Beer Marc D	NJ	DO	CEO	P	100	16.73	1	6	2	327	M				16	17	10	-2	-2	0	-1	12	-4	-26	-9
12/17/10 17:27	12/15/10	AEGR	Aegerion Pharmaceuticals, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Beer Marc D	NJ	DO	CEO	P	2	12.33	0	0	0	211	I					21	21	-4	-4	-7	21	25	31	52	38
10/27/10 17:43	10/27/10	AEGR	Aegerion Pharmaceuticals, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Beer Marc D	NJ	DO	CEO	P.d	1,000	9.50	2	105	New	105	D									10	2	-1	29	99	34

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person

Return to top

Contact